|Study Type:||Phase II|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase II clinical trial to evaluate the immunogenicity and safety of a combined regimen using ALVAC vCP1452 and AIDSVAX B/B
HVTN 203 is a Phase II clinical trial to evaluate the safety and immunogenicity of ALVAC vCP1452 and AIDSVAX B/B.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.